In these regions, its annual incidence is as high as 50 per 100 000, 2 and about 50% of patients, especially those with late stage experience recurrence after radical treatment, 1, 3, 4 suggesting that early diagnosis may decrease the recurrence risk and thus improve the outcome of NPC patients. Searching risk factors may help to identify the susceptible populations and increase the early diagnosis rate for NPC. In recent years, more and more studies reported that genomic DNA damage may be associated with NPC onset and progression, 5, 6 implying that malfunction of DNA repair pathways may be a risk factor and affect the susceptibility to this cancer. Indeed, several single-nucleotide polymorphisms (SNPs), such as 1349 T>G in the fifth exon (rs1130409) and −656 T>G in the promoter region (rs1760944) in the gene encoding apurinic/apyrimidinic endonuclease 1 (APEX1), [7] [8] [9] [10] which is a key player in the DNA base excision repair
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| Genotyping
Target fragments were amplified using the polymerase chain reaction (PCR) and primers designed with MassARRAY Assay Design Version Procedures were supplied by BGI (Beijing, China).
| Statistical analysis
Statistical analysis was performed using SPSS 17.0 (IBM, Chicago, IL, USA 
| RESULTS

| Characteristics of patients and controls
Genotype at the APEX1 SNP rs1760944 was successfully determined in all 477 NPC patients and 558 cancer-free controls in our study.
While the two groups did not differ significantly in age (P=.076), they did differ significantly in gender composition and smoking status (P<.001, Table 1 ). In addition, a significantly larger proportion of patients than controls was positive for Epstein-Barr virus (EBV)-related antibody (P<.001). Genotype frequencies at rs1760944 in the control group were consistent with HWE (P=.851; Table 2 ).
| Association of rs1760944 polymorphism with risk of NPC: all participants
The genotypes GT or GG at rs1760944 were significantly less frequent 
| DISCUSSION
In this study involving subjects from an endemic region, we found that the genotypes GT or GG at APEX1 rs1760944 were significantly less frequent in NPC patients than in controls, even after adjusting for sex, age and smoking history. This result suggests that this SNP may be associated with susceptibility to NPC, and specifically that genotypes GT or GG may confer reduced risk for disease in the populations from endemic areas. This is consistent with another study in a Chinese population from a different part of the country, which found a tendency for genotype GG to be associated with lower NPC risk. 7 How this SNP may affect APEX1 expression or activity is unclear. Since rs1760944 lies in the APEX1 promoter region, genotype GG may influence promoter activity and increase the level of APEX1 protein expression. 19 We suggest that the genotypes GG and GT in rs1760944 may lead to higher expression of APEX1 than genotype TT, and therefore, greater capacity to repair oxidative damage. This would explain why GG and GT appeared to protect against NPC in our study. 21 It is possible that these mood disorders are associated with higher levels of reactive oxidant species and oxidative stress, leading in turn to greater risk of many diseases, including cancer. APEX1 upregulation in the presence of genotypes GT or GG may increase repair capacity and thereby reduce NPC risk.
Our results suggest that the protective effect conferred by genotypes GT or GG depends on smoking status: the reduced risk was observed among never-smokers, but not among ever-smokers. The converse was observed in a previous study of a Chinese population from a different part of the country. 7 This discrepancy may reflect our small sample of ever-smokers, highlighting the need for larger studies in the future. The discrepancy may also reflect differences between the two study populations: ours was from the NPC endemic Guangxi region, while those in the previous study came from the non- than the levels in non-smokers. 27 Our own preliminary studies have also found a tendency toward higher serum levels of 8-OHdG among never-smokers with NPC than among ever-smokers with NPC (data not shown). We interpret these findings to indicate that cigarette smoking is likely to be only one of several factors that induce oxidative stress. Other factors include, for example, age and gender. 26,28. Whether the association between SNP rs1760944 and NPC risk depends on EBV infection cannot be addressed from our data. On one hand, the proportion of individuals positive for EBV-related antibody was significantly higher among NPC patients than among controls,
suggesting that EBV-VCA-IgA status could be contributing to our results. On the other hand, frequencies of the genotypes GT or GG did not significantly differ between patients and controls for the subgroup of individuals positive for EBV-VCA-IgA or for the subgroup negative for EBV-VCA-IgA (data not shown). Larger studies are needed to address whether EBV infection affects the relationships between these SNPs and NPC risk, especially given the high proportion of controls (544/558) and low proportion of patients (163/477) who were negative for EBV-related antibody.
Although gender composition and smoking history differed significantly between patients and controls in our study (Table 1) ,
we found no significant differences in genotype frequencies at rs1760944 between men and women or between never-smokers and ever-smokers (data not shown). Thus, it seems unlikely that this SNP varies with gender or smoking habit. In any event, we controlled for age, sex, and smoking status before performing stratification and adjustment analyses using logistic regression, 29 
| CONCLUSION
Our study suggests that the APEX1 SNP rs1760944 may be associ- 
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T A B L E 3 Distribution of APEX1 rs1760944 genotypes in nasopharyngeal carcinoma patients after stratification by age, sex, or smoking history Calculated by multiple logistic regression after controlling for the other two stratifying factors. For instance, the adjusted OR for different gender subgroups was adjusted for age and smoking history.
